Prevention of microsurgical anastomotic thrombosis using aspirin, heparin, and the glycoprotein IIb/IIIa inhibitor tirofiban

Plastic and Reconstructive Surgery

Volumn 120, Issue 5, 2007, Pages 1281-1288

  Chung, Thomas L ^b   Pumplin, David W ^b   Holton, Luther H ^b   Taylor, Jesse A ^b   Rodriguez, Eduardo D ^b   Silverman, Ronald P ^a  

^a UNIVERSITY OF MARYLAND MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; TIROFIBAN;

ANASTOMOSIS THROMBOSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMORAL ARTERY; FEMORAL VEIN; MALE; MICROVASCULAR SURGERY; NONHUMAN; PRIORITY JOURNAL; RAT; SPRAGUE DAWLEY RAT; SURGICAL TECHNIQUE; THERAPY EFFECT; THROMBOGENESIS; THROMBOSIS; THROMBOSIS PREVENTION; TREATMENT OUTCOME; TREATMENT RESPONSE; VASCULAR PATENCY;

ANASTOMOSIS, SURGICAL; ANIMALS; ANTICOAGULANTS; ASPIRIN; DRUG THERAPY, COMBINATION; HEPARIN; MALE; PLATELET AGGREGATION INHIBITORS; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; THROMBOSIS; TYROSINE; VASCULAR PATENCY;

EID: 34848928783     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.prs.0000279327.75083.ae     Document Type: Article

References (38)

1. Khouri, R. K., Cooley, B. C., Kunselman, A. R., et al. A prospective study of microvascular free-flap surgery and outcome. Plast. Reconstr. Surg. 102: 711, 1998.
2. English, J. M., and Tittle, B. J. Microsurgery: Free tissue transfer and replantation. Select. Read. Plast. Surg. 8: 16, 1997.
3. Waikakul, S., Sakkarnkosol, S., Vanadurongwan, V., et al. Results of 1018 digital replantation in 552 patients. Injury 31: 33, 2000.
4. Zumiotti, A., and Ferreira, M. C. Replantation of digits: Factors influencing survival and functional results. Microsurgery 15: 18, 1994.
5. Khouri, R. K. Free flap surgery: The second decade. Clin. Plast. Surg. 19: 757, 1992.
6. Adams, W. P., Jr., Anasari, M. S., Hat, M. T., et al. Patency of different arterial and venous end-to-side microanastomosis techniques in a rat model. Plast. Reconstr. Surg. 105: 156, 2000.
7. Acland, R. D. Thrombus formation in microvascular surgery: An experimental study of the effects of surgical trauma. Surgery 73: 766, 1973.
8. Tcheng, J. E. Clinical challenges of platelet glycoprotein IIb/IIIa receptor inhibitor therapy: Bleeding, reversal, thrombocytopenia, and retreatment. Am. Heart J. 139: S38, 2000.
9. Aguirre, F. V., Topal, E. J., Ferguson, J. J., et al. Bleeding complications with the chimeric antibody to platelet glycoprotein IIb/IIIa integrin in patients undergoing percutaneous coronary intervention. Circulation 91: 882, 1995.
10. Scarborough, R. M., Kleiman, N. S., and Phillips, D. R. Platelet glycoprotein IIb/IIIa antagonists: What are the relevant issues concerning their pharmacology and clinical use? Circulation 100: 437, 1999.
11. Berkowitz, S. D., Harrington, R. A., Rund, M. M., et al. Acute profound thrombocytopenia after C7E3 Fab (abciximab) therapy. Circulation 95: 809, 1997.
12. Barker, J. H., Acland, R. D., Anderson, G. L., et al. Microcirculatory disturbances following the passage of emboli in an experimental free-flap model. Plast. Reconstr. Surg. 90: 95, 1992.
13. Peter, F. W., Franken, R. J. P. M., Wang, W. Z., et al. Effect of low dose aspirin on thrombus formation at arterial and venous microanastomoses and on the tissue microcirculation. Plast. Reconstr. Surg. 99: 1112, 1997.
14. Wester, J., Sixma, J. J., Geuze, J., et al. Morphology of the early hemostasis in human skin wounds: Influence of acetylsalicylic acid. Lab. Invest. 39: 298, 1978.
15. Wester, J., Sixma, J. J., Geuze, J., et al. Morphology of the hemostatic plug in human skin wounds: Transformation of the plug. Lab. Invest. 41: 182, 1979.
16. Rooks, M. D., Rodriguez, J., Jr., Blechner, M., et al. Comparative study of intraarterial and intravenous anticoagulants in microvascular anastomoses. Microsurgery 15: 123, 1994.
17. Buckley, R. C., Davidson, S. F., and Das, S. K. The role of various antithrombotic agents in microvascular surgery. Br. J. Plast. Surg. 47: 20, 1994.
18. Greenberg, B. M., Masem, M., and May, J. W., Jr. Therapeutic value of intravenous heparin in microvascular surgery: An experimental vascular thrombosis study. Plast. Reconstr. Surg. 82: 463, 1988.
19. Johnson, P. C., and Barker, J. H. Thrombosis and antithrombotic therapy in microvascular surgery. Clin. Plast. Surg. 19: 799, 1992.
20. Cox, G. W., Runnels, S., Hsu, H. S. H., et al. A comparison of heparinized saline irrigation solutions in a model of microvascular thrombosis. Br. J. Plast. Surg. 45: 345, 1992.
21. Arnljots, G., Dougan, P., and Bergqvist, D. Antithrombotic and platelet activating effects of heparin in prevention of microarterial thrombosis. Plast. Reconstr. Surg. 99: 1122, 1997.
22. Zhang, B., and Weislander, J. B. Improvement of patency in small veins following dextran and/or low molecular weight heparin treatment. Plast. Reconstr. Surg. 94: 352, 1994.
23. Rothkopf, D. M., Chu, B., Bern, S., et al. The effect of dextran on microvascular thrombosis in an experimental rabbit model. Plast. Reconstr. Surg. 92: 511, 1993.
24. Romano, J. E., and Biel, M. A. Maintaining long-term vessel patency in microvascular surgery using tissue-type plasminogen activator. Otolaryngol. Head Neck Surg. 105: 391, 1991.
25. Atiyeh, B. S., Hashim, H. A., Hamdan, A. M., et al. Local recombinant tissue plasminogen activator thrombolytics therapy in microvascular surgery. Microsurgery 19: 265, 1999.
26. Rohrich, R. J., Handren, J., Kersh, R., et al. Prevention of microvascular thrombosis with short-term infusion of human tissue-type plasminogen activator. Plast. Reconstr. Surg. 98: 118, 1996.
27. Ching, S., Thoma, A., Monkman, S., et al. Inhibition of microsurgical thrombosis by the platelet glycoprotein IIb/IIIa antagonist SR121566A. Plast. Reconstr. Surg. 112: 177, 2003.
28. Yates, Y. J., Farias, C. L., Kazmier, F. R., et al. The effect of tirofiban on microvascular thrombosis: Crush model. Plast. Reconstr. Surg. 116: 205, 2005.
29. Conrad, M. H., and Adams, W. P., Jr. Pharmacologic optimization of microsurgery in the new millennium. Plast. Reconstr. Surg. 108: 2088, 2001.
30. Johnson, P. C. Platelet-mediated thrombosis in microvascular surgery: New knowledge and strategies. Plast. Reconstr. Surg. 86: 359, 1990.
31. Coller, B. S., Anderson, K. M., and Weiman, H. R. The anti-GPIIb/IIIa agents: Fundamental and clinical aspects. Haemostasis 26(Suppl. 4): 285, 1996.
32. Hjortdal, V. E., Hauge, E., and Hansen, E. S. Differential effects of venous stasis and arterial insufficiency on tissue oxygenation in myocutaneous island flaps: An experimental study in pigs. Plast. Reconstr. Surg. 89: 521, 1992.
33. Bennett, J. S. Platelet-fibrinogen interactions. Ann. N. Y. Acad. Sci. 936: 340, 2001.
34. Ferguson, J. J., Waly, H. M., and Wilson, J. M. Fundamentals of coagulation and glycoprotein IIb/IIIa receptor inhibition. Am. Heart J. 135: S35, 1998.
35. Cohen, M., Ferguson, J. J., III, and Harrington, R. A. Trials of glycoprotein IIb-IIIa inhibitors in non-ST-segment elevation acute coronary syndromes: Applicability to the practice of medicine in the United States. Clin. Cardiol. 22(Suppl. 6): VI2, 1999.
36. The Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) Study Investigators. Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction. N. Engl. J. Med. 338: 1488, 1998.
37. Cannon, C. P., Weintraub, W. S., Demopoulos, L. A., et al. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N. Engl. J. Med. 344: 1879, 2001.
38. The Platelet Receptor Inhibition in Ischemic Syndrome Management (PRISM) Study Investigators. A comparison of aspirin plus tirofiban with aspirin plus heparin for unstable angina. N. Engl. J. Med. 338: 1498, 1998.